Budai Irgalmasrendi Korhaz

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Heart failure1 trial
• Stroke1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Bayer1 trial
• Faraday Pharmaceuticals, Inc.1 trial

Closed trials

• Completed

  Evaluation in STEMI Patients Using FDY-5301

  NCT04837001· Phase 3· Faraday Pharmaceuticals, Inc.· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Bayer· Source